scholarly journals Mirizzi Syndrome: Four Case Reports and a Review of the Literature

2018 ◽  
Vol 02 (01) ◽  
Author(s):  
Gerond Lake Bakaar ◽  
Min Yoo ◽  
David Cronin
2011 ◽  
Vol 96 (3) ◽  
pp. 228-232 ◽  
Author(s):  
Petar B. Petricevic ◽  
Olga M. Kontic ◽  
Miomira Z. Petricevic ◽  
Marko M. Kontic ◽  
Geza Smit

Abstract The authors have analyzed the problem of Mirizzi syndrome (MS) and found in the literature that it was reported in 0.3% to 3% of patients undergoing cholecystectomy. Anatomic disorder, especially the presence of cholecystocholedochal fistula, increases the risk of bile duct injury during cholecystectomy, albeit more often during laparoscopic than laparotomic cholecystectomy. A comparative study was performed regarding the incidence of MS in two groups of patients: 332 patients in Zrenjanin in the year 2009, and 531 patients in Belgrade in the year 2005, with an incidence of MS found in 2 patients in Zrenjanin (0.63%) and 4 patients in Belgrade (0.75%). The incidence rate was 6% in Zrenjanin and 7.5% in Belgrade, but there was no statistically significant difference between the two groups. All patients with MS were diagnosed during the operative period using operative cholangiography. During preoperative diagnosis, patients underwent laboratory ultrasound examination, and those who were suspected of having an anatomic disorder underwent operative cholangiography, although patients today more often undergo choledochoscopy then cholangiography. MS according to classification by Csendes was found in all 6 patients undergoing operation.


2019 ◽  
Vol 19 (2) ◽  
pp. e271-e275 ◽  
Author(s):  
Sara Tanini ◽  
Alessandra D. Fisher ◽  
Icro Meattini ◽  
Simonetta Bianchi ◽  
Jiska Ristori ◽  
...  

Author(s):  
Márcia Marinho ◽  
Sara Nunes ◽  
Cátia Lourenço ◽  
Mónica Melo ◽  
Cristina Godinho ◽  
...  

Author(s):  
Mateusz Kozłowski ◽  
Katarzyna Nowak ◽  
Agnieszka Kordek ◽  
Aneta Cymbaluk-Płoska

Carcinosarcoma, leiomyosarcoma, melanoma and carcinoid as primary tumors in the ovary are extremely rare. In this paper, the authors reviewed the literature from 2010 to 2021, based on specific criteria, to analyze the treatment of these rare ovarian neoplasms. We also aimed to verify whether modern therapies have been found in recent years. For this article, 80 papers were finally selected. The vast majority of the articles were clinical case reports. Despite single mentions of new potential pharmacological treatments, surgery (radical or fertility-sparing) is definitely the mainstay of treatment. There are currently no treatment guidelines for these tumors. A review of the literature has revealed the use of various adjuvant treatments. We, therefore, believe that a more detailed understanding of the biology of these tumors is necessary in order to find new target points for treatment. We would like to emphasize the importance of creating an international database of rare ovarian tumors which would make it possible to gather data from various oncological centers and enable further research into these neoplasms.


2021 ◽  
Vol 81 ◽  
pp. 105720
Author(s):  
Youssef Oukessou ◽  
Yassir Hammouda ◽  
Khadija El Bouhmadi ◽  
Redallah Larbi Abada ◽  
Mohamed Roubal ◽  
...  

1994 ◽  
Vol 152 (5 Part 1) ◽  
pp. 1568-1571 ◽  
Author(s):  
Joseph G. Borer ◽  
Kenneth I. Glassberg ◽  
E. George Kassner ◽  
David A. Schulsinger ◽  
Unni M.M. Mooppan

1995 ◽  
Vol 70 (6) ◽  
pp. 570-572 ◽  
Author(s):  
Vincent Baty ◽  
Bruno Hoen ◽  
Hervé Hudziak ◽  
Catherine Aghassian ◽  
Claude Jeandel ◽  
...  

2000 ◽  
Vol 118 (4) ◽  
pp. A1150-A1151
Author(s):  
Wolfgang Mohl ◽  
Markus Menges ◽  
Cornelius Moser ◽  
Gemot Feifel ◽  
Bernhard Kramann ◽  
...  

2004 ◽  
Vol 25 (6) ◽  
pp. 465-468 ◽  
Author(s):  
Ercan Cetinus ◽  
Ilhan Cever ◽  
Cemal Kural ◽  
Haldun Erturk ◽  
Mustafa Akyildiz

Sign in / Sign up

Export Citation Format

Share Document